Isoform | INDUCER | Donors with >2-Fold Induction at Each Time Point | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
6 | 12 | 24 | 48 | 72 | |||||||
mRNA | Activity | mRNA | Activity | mRNA | Activity | mRNA | Activity | mRNA | Activity | ||
% | |||||||||||
CYP1A2 | Omeprazole | 67 | 25 | 75 | 67 | 100 | 100 | 100 | 100 | 100 | 100 |
Phenobarbital | 40 | 50 | 80 | 75 | 60 | 75 | 67 | 100 | 57 | 86 | |
CYP2B6 | Efavirenz | 86 | 0 | 100 | 0 | 100 | 0 | 100 | 100 | 83 | 100 |
Phenobarbital | 86 | 50 | 100 | 60 | 100 | 100 | 100 | 100 | 100 | 100 | |
Rifampicin | 67 | 50 | 100 | 75 | 83 | 83 | 100 | 100 | 100 | 100 | |
CYP2C9 | Rifampicin | 0 | ND | 33 | ND | 75 | ND | 100 | ND | 100 | ND |
CYP3A4 | Efavirenz | 60 | 33 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Rifampicin | 100 | 0 | 100 | 80 | 100 | 100 | 100 | 100 | 100 | 100 | |
Donors with >10-Fold Induction at Each Time Point | |||||||||||
Rifampicin | 20 | 0 | 83 | 0 | 100 | 33 | 86 | 17 | 86 | 50 |
ND, Not determined.